Eastman Chemical (NYSE: EMN) reported Q1 EPS of $1.61, $0.18 better than the analyst estimate of $1.43. Revenue for the quarter came in at $2.31 billion versus the consensus estimate of $2.29 billion.

GUIDANCE:

Eastman Chemical sees FY2024 EPS of $7.25-$8.00, versus the consensus of $7.67.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.